PMID: 18981485 Chapman IM, et al
The primary antibodies employed were: P53 (Proteintech, 60283-2-Ig), pSer46-P53 (CST, 2521), FOXO4 (Proteintech, 21535-1-AP), P21 (CST, 2947), P16 (CST, 18769), BAX (CST, 2772), BCL2 (CST, 3498), Ki-67 (Proteintech, 84192-4-RR), Lamin B (CST, 13435), Cleaved Caspase 3 (CST, 9664), -H2AX (Abcam, ab81299), and GAPDH (Abcam, ab8245) as an internal reference for normalizing protein expression levels
The study did not find clear associations between improvement and baseline BMI, baseline HbA1c, age at HS diagnosis, GLP-1RA duration, or smoking status in this cohort
If you are new to resistance training, start with bodyweight exercises or light weights and progress gradually
The Medicare GLP-1 Bridge specifically covers the weight management indications, so Ozempic and Mounjaro are not part of the bridge program
Actual peer-reviewed research in indexed medical journals